IP Library Patent Application 15061733
Patent Application
App. No. 15/061,733

PROCESS FOR PREPARING OXYCODONE COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/061,733
Abstract

In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.

Claims (15)

1 - 79 . (canceled)

80 . A process for preparing an oxycodone composition comprising:

subjecting a first oxycodone composition comprising a first amount of 14-hydroxycodeinone to chromatographic separation to preferentially remove 14-hydroxycodeinone as compared to oxycodone; and

recovering a second oxycodone composition comprising a second amount of 14-hydroxycodeinone;

wherein the second amount of 14-hydroxycodeinone is lower than the first amount of 14-hydroxycodeinone.

81 . The process of claim 80 , wherein the second amount is less than 100 ppm.

82 . The process of claim 81 , wherein the second amount is less than 25 ppm.

83 . The process of claim 82 , wherein the second amount is less than 10 ppm.

84 . The process of claim 83 , wherein the second amount is less than 5 ppm.

85 . The process of claim 81 , wherein the second amount is 0.25 ppm or more.

86 . The process of claim 85 , wherein the second amount is 1 ppm or more.

87 . The process of claim 80 , wherein the chromatographic separation is a simulated moving bed.

88 . The process of claim 80 , wherein the process is for preparing an oxycodone hydrochloride composition.

89 . The process of claim 80 , wherein the process is for preparing an oxycodone hydrochloride active pharmaceutical ingredient composition.

90 . The process of claim 80 , wherein the process is for preparing an oxycodone hydrochloride active pharmaceutical ingredient composition comprising less than 25 ppm 14-hydroxycodeinone.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2019
From: THE P.F. LABORATORIES, INC.; PURDUE PHARMA TECHNOLOGIES, INC.
To: PURDUE PHARMA L.P.
Reel/Frame 048936/0093 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2016
From: CHAPMAN, ROBERT; RIDER, LONN S.; HONG, QI; KYLE, DONALD; KUPPER, ROBERT
To: EURO-CELTIQUE S.A.
Reel/Frame 040033/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2016
From: EURO-CELTIQUE S.A.
To: PURDUE PHARMA L.P.
Reel/Frame 040034/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2016
From: PURDUE PHARMA L.P.
To: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.; RHODES TECHNOLOGIES
Reel/Frame 040034/0442 →